Illumina plans to lower its yearly running costs by approximately $100m over the course of 2023, with reductions in headcount accounting for most of the planned savings, according to a 21 June 8K report filed with the US Securities and Exchange Commission.
The sequencing company’s workforce stood at just over 10,000 people, according to prior filings this year, and it is rumored that
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?